This Year, PBM-Directed Fury May Once Again Signify Nothing

  • Jan 09, 2025

    While federal legislators failed to act on the rising tide of anti-PBM sentiment in 2024, health policy experts are predicting that the risk of regulatory intervention will ramp up this year — even with Republicans, who traditionally are viewed as business friendly, controlling Congress and the White House. 

    Yet some industry observers appear to be skeptical about how effective federal PBM reforms would be — especially because major PBMs will likely continue to see demand for their services while also embracing innovation. 

    Read more
    © 2024 MMIT
  • Leslie Small

    Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

The Latest
Meet Our Reporters

Meet Our Reporters

×